Jeffrey Sevigny is a New York, New York based neurologist who is specialized in Neurology. Active license number of Jeffrey Sevigny is 220335 for Neurology in New York. His current practice location is 10 Union Sq E, New York. Patients can reach him at 212-844-8888. Jeffrey Sevigny NPI number (Unique professional ID assigned by NPPES) is 1922099431. Jeffrey Sevigny specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Jeffrey Sevigny speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Jeffrey Sevigny
Specialization:
Neurology
Gender:
Male
Practice Address:
10 Union Sq E, New York, New York, 10003-3314
Phone:
212-844-8888
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1922099431
NPI Enumeration Date:
03 Nov, 2005
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jeffrey Sevigny are as mentioned below.
License Number
Specialization
State
Status
220335
Neurology
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Jeffrey Sevigny Gpo Box 5806, New York, New York
Zip:
10087-5806
Phone Number:
212-256-3539
Patients can reach Jeffrey Sevigny at 10 Union Sq E, New York, New York or can call to book an appointment on 212-844-8888.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.